"AIG Hospitals is a unit of the Asian Institute of Gastroenterology, India’s foremost Gastroenterology hospital. Spread across 1.4 million sq.ft, with a state-of-the-art 1000-bed super specialty Hospital, which is among the largest hospitals in the country today. The Hospital has been custom designed to undertake transplant surgeries including Liver, Kidney, Heart, Pancreas, and Islet Cell. All the above services will be well supported by active Emergency and Critical Care services to ensure sick patients get the care they truly deserve. AIG Hospitals is now a Multispecialty Hospital."

During the past decade, AIG Hospitals conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AIG Hospitals" #1 sponsor was "Asian Institute of Gastroenterology, India" with 10 trials, followed by "Dr. Reddy's Laboratories Limited" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Marco J. Bruno" with 1 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AIG Hospitals" #1 collaborator was "Boston Scientific Corporation" with 1 trials as a collaborator, "CRO: JSS Medical Research India Pvt. Ltd." with 1 trials as a collaborator, "Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation" with 1 trials as a collaborator and "Russian Direct Investment Fund" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "AIG Hospitals" are "Achalasia Cardia" (1 trials), "Atrial Fibrillation" (1 trials), "COVID-19 Prevention" (1 trials), "Cholangiopancreatography, Endoscopic Retrograde" (1 trials) and "Cirrhosis" (1 trials). Many other conditions were trialed in "AIG Hospitals" in a lesser frequency.

Most popular intervention types in "AIG Hospitals" are "Diagnostic Test" (3 trials), "Procedure" (3 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "24 hour pH & impedance monitoring" (1 trials), "99mTc Scintigraphy" (1 trials), "Electrogastrography" (1 trials) and "Gam-COVID-Vac" (1 trials). Other intervention names were less common.

The vast majority of trials in "AIG Hospitals" are 14 trials for "All" genders.

Currently, there are NaN active trials in "AIG Hospitals". undefined are not yet recruiting, 8 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in AIG Hospitals, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AIG Hospitals, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".